Navigation Links
WeissComm Partners Names Tom Jones Managing Director to Deepen Global Product Communications Offering
Date:2/19/2008

NEW YORK and SAN FRANCISCO, Feb. 19 /PRNewswire/ -- WeissComm Partners, the largest independent communications agency focused on the healthcare industry, today announced the appointment of Tom Jones as managing director. Jones joins WeissComm from Novartis Pharmaceuticals Corporation where he was executive director of communications, overseeing the creation, development and implementation of public relations programs for the company's growth driver brands. Prior to that, he was vice president and group manager at Ketchum where he contributed greatly to the growth of the healthcare practice.

For more than 15 years, Jones has developed and executed award-winning public relations and corporate communications initiatives, built and managed high-performance teams, and provided measurable business results for leading pharmaceutical and biotechnology companies, including AstraZeneca, Aventis, Genentech, Merck, Novartis and Pfizer.

"PR has never been more important to the healthcare industry," said Diane Weiser, COO of WeissComm Partners. "Tom is a trusted colleague with a proven track record who can hit the ground running to provide clients with the no-nonsense, on-target, strategic counsel and execution they have come to expect from our team."

Jones has directed consumer and professional communications programs on behalf of some of the world's largest prescription medicines across a broad range of therapeutic areas, including neurology, cardiology, diabetes, respiratory, dermatology, arthritis and gastrointestinal disorders. As part of these initiatives, he has developed and managed corporate and brand communications, consumer and professional outreach, issues management, media and advocacy relations, corporate reputation management, leadership communications, internal communications and new media initiatives.

"I joined WeissComm to be part of a truly senior-based team of healthcare professionals and apply my agency and corporate in-house experience to a diverse group of healthcare clients," said Jones. "I am looking forward to working with respected and trusted peers and colleagues to expand WeissComm's global product communications offering and continue to raise the bar on its client-agency partnerships."

About WeissComm Partners

WeissComm Partners is a full-service public relations agency focused exclusively on serving the corporate and product communications needs of leading biotechnology, pharmaceutical, device and diagnostic companies. At WeissComm, senior counselors are the client's everyday team. WeissComm's team of seasoned professionals specialize in healthcare marketing, corporate and product PR, investor and advocacy relations, clinical trial recruitment and grassroots direct-to-patient PR programs. Ranked among the top independent PR firms in the United States, WeissComm serves clients globally with offices in San Francisco, New York and Chicago, and in London via a strategic alliance with Resolute Communications. For more information, please visit http://www.wcpglobal.com.


'/>"/>
SOURCE WeissComm Partners
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
2. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. MDS to Present at Thomas Weisel Partners Healthcare Conference
8. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
9. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer ... Molecular Medicine Tri-Conference February 20 – 22 in San Francisco. As part of ... anatomic and molecular pathology workflow solution, as well as its new precision medicine ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason Pasquin Agency, ... and business owners in and around the Hampton Roads metropolitan region, is joining ... forms of domestic violence. , There are multiple categories of domestic violence – ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017 Research and Markets has announced the ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:2/17/2017)... ST. LOUIS , Feb. 17, 2017   ... hospitals, has announced a new partnership with Engage ... the United States . FormFast will serve ... part of Engage,s implementations with MEDITECH .  ... that provides essential functionality to complement and enhance the ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017  Noble ... coverage on ESSA Pharma Inc. (Nasdaq: EPIX ... Biotechnology Research, Kumar Raja , PhD. ... treatments for castration resistant prostate cancer (CRPC). Its lead ... selectively blocks the amino-terminal domain of the androgen receptor, ...
Breaking Medicine Technology: